ALPHA TRIBE

Natco Pharma LimitedUpdates, 10-10-2025: Press Release

10-10-2025 | 01:07 pm

NATCO Pharma's proposed acquisition of Adcock Ingram shares progressed as the Scheme Resolution passed with 98.66% votes. The ZAR 75.00 per share consideration is pending final conditions, leading to Adcock Ingram's delisting and marking a significant business development.

No comments yet. Be the first to comment!

All announcements from Natco Pharma Limited